Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. - Wikidata - awgldk - TriplyDB

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

http://www.wikidata.org/entity/Q34193315

about

Update on treatment of light chain amyloidosis Nuclear imaging modalities for cardiac amyloidosis Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation.AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human Cardiomyocytes Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging A novel method for quantifying peripheral tissue amyloid load by using the radiolabeled amyloidophilic peptide, p5.Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts.Molecular imaging of amyloidosis: will the heart be the next target after the brain?Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis.18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.Nuclear imaging for cardiac amyloidosis.The Critical Role of Imaging in the Management of Multiple Myeloma.Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis.Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.A Peptide-Fc Opsonin with Pan-Amyloid Reactivity Development and evaluation of agents for targeting visceral amyloid.Generation and characterization of anti-AA amyloid-specific monoclonal antibodies.Autologous stem cell transplant for Al amyloidosis.Copper-64-labeled daratumumab as a PET/CT imaging tracer for multiple myeloma.Pretargeting immunotherapy: a novel treatment approach for systemic amyloidosis.Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

P2860

Q26829735-6D58E09D-105C-4C71-8376-6E7432DFC09A Q27024756-041CFA4B-FC53-41E4-8FE6-231B591CDEC2 Q34144814-87C7065E-24A7-42B5-91D0-5B74266B0E76 Q34216798-75FD25DE-9B29-4C92-9802-D1DEA45C9FC3 Q34541038-DD11C192-0E9E-46CB-8D80-F153C495441E Q35180876-F7A8774A-FD75-4BAA-953D-44108FBAB3CB Q35639988-E05D244C-F249-42EA-AECD-EB968D46AB3F Q35656129-1B861773-04A0-450E-9DD0-C5D1AFF0D0FE Q35783283-CCF054DC-7BCC-4C62-85C7-B19AE366F257 Q36325334-1C28A733-6B50-4D27-A8F3-4AC68F353787 Q36769236-E1B37B4C-E297-4821-BF2A-682AA3914BEE Q37010197-B382D94C-689E-4D06-B0D4-C5BBF8A93E2D Q37076423-A86CF33C-4BA8-49D4-87B7-31AAB3246EF4 Q37970935-F2F49B76-1170-4999-A161-D7D488018841 Q37999957-4D21D1A5-E7BC-4248-B50F-5AB58FFEF71D Q38010222-DF19677F-A3D7-464D-91C4-2DCB413754F1 Q38271439-3DD299FB-27C2-4513-8598-4E32D7A37F3A Q39186780-F3D6BA74-A57F-4357-956A-EC1844DB7D62 Q39309126-EB219AD1-AE47-4565-94BD-19DB954ABBAD Q40316884-3A4D857D-3D6F-4955-92E2-BCFD4C3EDB23 Q40737924-A35712DB-205B-456D-9915-5646506CD319 Q41471564-4D1DBB6D-1B8F-4533-A677-09AF859FD0A9 Q41814084-D15F850D-6385-47BD-B4F8-E6FD31177B43 Q41861063-30EDEF51-F579-47C0-89A5-9BD143D6DDFE Q42179759-ABCF3A61-C407-4ADF-968C-06154E8E57B4 Q47561677-E6DEC634-5025-42AC-9FF3-3C952708F0D0 Q47927900-CFD3F2D2-5CB0-4B1C-94D7-A26FB9B68D9F Q58172626-E080058C-7208-4297-98E2-142670B9FD50

P2860

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

http://www.wikidata.org/entity/Q34193315

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@ast

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@en

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@nl

type

label

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@ast

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@en

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@nl

prefLabel

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@ast

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@en

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@nl

P1433

Q34193315-2FA4A4F0-BB4C-498E-B80B-6620439C8CA2

P1476

Q34193315-EF429CAA-9A6E-437E-95D5-742E7D7EDB56

P2093

Q34193315-0D8FDCF5-97CC-40A0-99AA-D9896B021851

Q34193315-5349C362-4CA2-4AD8-9172-DDCCF4C11CCE

Q34193315-602AD9C5-7B6E-4AE7-966C-7A7127325D02

Q34193315-84394DD8-B57A-4055-AFC1-C575A7600E35

Q34193315-998F804D-E7B4-45F0-B4A1-586902D4A029

Q34193315-AF6E2979-25F8-42EE-92CD-CA4E698AFAFA

Q34193315-BAC2B5D9-E912-4FDA-9A59-68E28EF7F826

Q34193315-D8182545-ECC6-4365-9A1B-7D62069BE1E9

Q34193315-E04E44F2-9AF2-49BB-9766-311466D1B094

Q34193315-E1812086-C10D-47B3-8721-4D10C57BEFC5

P2860

Q34193315-085B5320-09C1-422A-B245-35B17883C882

Q34193315-19C66264-7A3C-42D0-A34E-4A43A262E6AE

Q34193315-1F6E880E-0A47-4548-AA47-7CF3DCBE7A92

Q34193315-2261B58B-7540-4FE5-945E-491D796702D3

Q34193315-55D7F911-C60E-42DD-8659-B28B110CC693

Q34193315-5F250646-0FAC-4042-8407-D64FAE686E1B

Q34193315-6E06ACDF-B148-4DEB-AFF9-145117E7B7F3

Q34193315-71620878-26C9-4F4B-9407-522E160C222A

Q34193315-8275269D-0EF1-4892-B871-B5276D548AA2

Q34193315-97E9F877-3809-4C7C-BCFC-AA9059FBE285

P304

Q34193315-AB834139-7CFF-450D-A8C7-A9DCF71AA531

P31

Q34193315-7A18C86B-09DE-4E97-944F-31881F825573

P356

Q34193315-77EA2428-E915-41A0-89DC-8930E8F526D1

P407

Q34193315-C928712F-EF3D-4E05-AB20-774037D0018D

P433

Q34193315-3CDEAD4D-B131-4E37-AD3B-12FC30458534

P478

Q34193315-24197046-A89E-47B7-B277-3417339F4596

P577

Q34193315-F2493596-22B5-4ADD-BD06-783C0C697E1F

P5875

Q34193315-D30A68E8-872E-48D9-B46A-27F54632D614

P698

Q34193315-E65B5235-9852-489B-BF6F-631059C02662

P932

Q34193315-EB30BF3B-6035-4B06-A6AD-546A9BA1CB99

P356

BLOOD-2010-03-273797

P1433

P1476

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

@en

P2093

Alan C Stuckey

http://www.w3.org/2001/XMLSchema#string

Alan Solomon

http://www.w3.org/2001/XMLSchema#string

David W Townsend

http://www.w3.org/2001/XMLSchema#string

Deborah T Weiss

http://www.w3.org/2001/XMLSchema#string

Gary T Smith

http://www.w3.org/2001/XMLSchema#string

Jonathan S Wall

http://www.w3.org/2001/XMLSchema#string

Karen J Wells

http://www.w3.org/2001/XMLSchema#string

Michael G Stabin

http://www.w3.org/2001/XMLSchema#string

Misty J Long

http://www.w3.org/2001/XMLSchema#string

Stephen J Kennel

http://www.w3.org/2001/XMLSchema#string

P2860

Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Autologous stem cell transplantation for primary systemic amyloidosis.

Amyloidosis: prognosis and treatment.

Molecular mechanisms of amyloidosis.

Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.

Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.

Antibody-mediated resolution of light chain-associated amyloid deposits.

P304

2241-2244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2010-03-273797

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44648735

http://www.w3.org/2001/XMLSchema#string

P698

20522711

http://www.w3.org/2001/XMLSchema#string

P932

2953836

http://www.w3.org/2001/XMLSchema#string